US 9,808,495 B2
Compositions and methods for modulating lipid composition
Robert A. Newman, Surry, ME (US); Peiying Yang, Sugar Land, TX (US); and Paul Schulick, Brattleboro, VT (US)
Assigned to The Procter & Gamble Company, Cincinnati, OH (US)
Filed by Robert A. Newman, Surry, ME (US); Peiying Yang, Sugar Land, TX (US); and Paul Schulick, Brattleboro, VT (US)
Filed on May 28, 2010, as Appl. No. 12/790,533.
Claims priority of provisional application 61/213,334, filed on May 29, 2009.
Claims priority of provisional application 61/272,130, filed on Aug. 19, 2009.
Prior Publication US 2011/0008457 A1, Jan. 13, 2011
Int. Cl. A61K 36/53 (2006.01); A61K 35/60 (2006.01); A61K 45/06 (2006.01)
CPC A61K 36/53 (2013.01) [A61K 35/60 (2013.01); A61K 45/06 (2013.01)] 23 Claims
 
1. A capsule of a stable therapeutic composition comprising about 0.2 wt % supercritical extract (SCE) of rosemary, about 0.4 wt % supercritical extract of oregano, and 97 to 99.4 wt % salmon oil.